Alzheimer Disease 11

Known as: AD11, Alzheimer Disease, Familial, 11 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1982-2014
01219822014

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
Many approaches exist to integrate protein-protein interaction data with other sources of information, most notably with gene co… (More)
  • figure 1
  • table 1
  • table 2
  • figure 2
  • figure 3
Is this relevant?
2014
2014
Adult neurogenesis is a multistep process regulated by several extrinsic factors, including neurotrophins. Among them, little is… (More)
Is this relevant?
2010
2010
NGF, the principal neurotrophic factor for basal forebrain cholinergic neurons (BFCNs), has been correlated to Alzheimer's… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2009
2009
Nerve growth factor (NGF) has a great potential for the treatment of Alzheimer's disease. However, the therapeutic administration… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2007
2007
Alzheimer's disease (AD) is a devastating neurodegenerative disorder characterized by progressive memory deficits and cognitive… (More)
Is this relevant?
2006
2006
A deficit in cortical cholinergic synaptic transmission is a common feature of cognitive and behavioral impairment observed in… (More)
Is this relevant?
Review
2006
Review
2006
1. Alzheimer’s disease (AD) is pathologically defined by the deposition of amyloid peptide and neurofibrillary tangles and is… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2004
2004
Ganstigmine (CHF2819) is an acetylcholinesterase inhibitor that increases acetylcholine in rat hippocampus and ameliorates… (More)
Is this relevant?
Highly Cited
2002
Highly Cited
2002
Phenotypic knockout of nerve growth factor (NGF) activity in transgenic anti-NGF mice (AD11 mice) results in a progressive… (More)
Is this relevant?